GlassScriptPhysician profile
Katie S Artz
NPI 1396781860
$103,325.44
in general payments reported to CMS, 2019-2025
26 companies · $6,525 in 2025
The $6,525 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $15K · 2021: $18K · 2022: $30K · 2023: $29K · 2024: $4,415 · 2025: $6,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Travel and Lodging: $5,400 · Food and Beverage: $4,027 · Education: $4,000 · Consulting Fee: $450 · Gift: $44.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $19,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Travel and Lodging | $5,400.28 |
| Food and Beverage | $4,027.23 |
| Education | $4,000.00 |
| Consulting Fee | $450.00 |
| Gift | $44.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $51,156.94 | 2020-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Davol INC. | $50,017.17 | 2019-2025 | Phasix Mesh, Pyxis |
| Becton, Dickinson and Company | $902.59 | 2024 | Phasix Mesh |
| Stryker Corporation | $275.26 | 2022-2023 | Mako |
| Hologic Sales and Service, LLC | $194.31 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $189.70 | 2021-2023 | Gattex |
| Tela Bio, INC. | $101.11 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mimedx Group, INC. | $70.91 | 2024-2025 | |
| Tetraphase Pharmaceuticals, INC. | $41.18 | 2019 | |
| Merck Sharp & Dohme LLC | $32.90 | 2019-2021 | |
| Boston Scientific Corporation | $30.80 | 2022 | |
| Medtronic, INC. | $30.45 | 2022 | |
| Ambu INC. | $29.63 | 2022 | |
| Polynovo North America LLC | $29.52 | 2021 | |
| Coloplast Corp | $27.83 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $22.62 | 2023 | Hemoblast Bellows |
| Pacira Pharmaceuticals Incorporated | $21.05 | 2019 | |
| Elucent Medical | $20.65 | 2023 | |
| Biom'Up Sa | $20.40 | 2019 | |
| Covidien LP | $19.67 | 2019 | |
| Shire North American Group INC | $19.53 | 2019 | |
| Advanced Oxygen Therapy INC. | $16.86 | 2023 | Topical Oxygen Chamber For Extremities |
| Regeneron Healthcare Solutions, INC. | $15.76 | 2023 | Libtayo |
| Olympus America INC. | $14.90 | 2023 | Olympus |
| Acacia Pharma INC | $12.17 | 2021 | |
| Medela LLC | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Artz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.